{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T04:09:06Z","timestamp":1778731746143,"version":"3.51.4"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,2,19]],"date-time":"2019-02-19T00:00:00Z","timestamp":1550534400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012543","name":"Shanghai Science and Technology Development Foundation","doi-asserted-by":"publisher","award":["16DZ0501000"],"award-info":[{"award-number":["16DZ0501000"]}],"id":[{"id":"10.13039\/100012543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.biopha.2019.108701","type":"journal-article","created":{"date-parts":[[2019,2,25]],"date-time":"2019-02-25T12:30:30Z","timestamp":1551097830000},"page":"108701","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Protective effect of cultured bear bile powder against dimethylnitrosamine-induced hepatic fibrosis in rats"],"prefix":"10.1016","volume":"112","author":[{"given":"Min","family":"Zheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan-Yuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guo-Feng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing-Yi","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya-Hang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tian-Ming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shao-Yong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia-Sheng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0149-2855","authenticated-orcid":false,"given":"Zheng-Tao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue-Ming","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.biopha.2019.108701_bib0005","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1159\/000445269","article-title":"New developments on the treatment of liver fibrosis","volume":"34","author":"Koyama","year":"2016","journal-title":"Dig. Dis."},{"issue":"6","key":"10.1016\/j.biopha.2019.108701_bib0010","doi-asserted-by":"crossref","first-page":"505","DOI":"10.2174\/138945009788488459","article-title":"Liver fibrosis and therapeutic strategies: the goal for improving metabolism","volume":"10","author":"Balsano","year":"2009","journal-title":"Curr. Drug Targets"},{"issue":"5","key":"10.1016\/j.biopha.2019.108701_bib0015","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S2095-4964(14)60039-X","article-title":"Traditional Chinese medicine for treatment of liver diseases: progress, challenges and opportunities","volume":"12","author":"Zhao","year":"2014","journal-title":"J. Integr. Med."},{"key":"10.1016\/j.biopha.2019.108701_bib0020","article-title":"Substitutes for bear bile for the treatment of liver diseases: research progress and future perspective","volume":"2016","author":"Li","year":"2016","journal-title":"Evid. Complement. Alternat. Med."},{"issue":"02","key":"10.1016\/j.biopha.2019.108701_bib0025","first-page":"25","article-title":"Clinical study of the effect of Xiongdan jiaonang on viral hepatitis","author":"Shan","year":"2000","journal-title":"Sichuan Med. J."},{"issue":"01","key":"10.1016\/j.biopha.2019.108701_bib0030","first-page":"40","article-title":"Treatment of 33 cases of chronic hepatitis B with high jaundice with Xiongdan jiaonang","author":"Sheng Lei","year":"2004","journal-title":"J. Clin. Hepatol."},{"issue":"7","key":"10.1016\/j.biopha.2019.108701_bib0035","first-page":"150","article-title":"Medicinal use and substitution of bear gall bladder","volume":"43","author":"Feng","year":"2015","journal-title":"J. Anhui Agric. Sci."},{"key":"10.1016\/j.biopha.2019.108701_bib0040","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/1472-6882-12-239","article-title":"A comparative study on the hepatoprotective action of bear bile and Coptidis Rhizoma aqueous extract on experimental liver fibrosis in rats","volume":"12","author":"Wang","year":"2012","journal-title":"BMC Complement. Altern. Med."},{"key":"10.1016\/j.biopha.2019.108701_bib0045","unstructured":"Tao HJ, Y.M., Lu B, People\u2019s Medical Publishing House (PMPH). 1986: Beijing, China. 79."},{"issue":"57","key":"10.1016\/j.biopha.2019.108701_bib0050","doi-asserted-by":"crossref","first-page":"97137","DOI":"10.18632\/oncotarget.21385","article-title":"Chicken bile powder protects against alpha-naphthylisothiocyanate-induced cholestatic liver injury in mice","volume":"8","author":"Li","year":"2017","journal-title":"Oncotarget"},{"issue":"7216","key":"10.1016\/j.biopha.2019.108701_bib0055","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/4551054a","article-title":"Systems biology: metabonomics","volume":"455","author":"Nicholson","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2019.108701_bib0060","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jpba.2012.09.021","article-title":"Urinary metabonomics characterization of liver fibrosis induced by CCl(4) in rats and intervention effects of Xia Yu Xue Decoction","volume":"74","author":"Gou","year":"2013","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.biopha.2019.108701_bib0065","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.talanta.2017.09.046","article-title":"Assessment of potential false positives via orbitrap-based untargeted lipidomics from rat tissues","volume":"178","author":"Xu","year":"2018","journal-title":"Talanta"},{"issue":"1","key":"10.1016\/j.biopha.2019.108701_bib0070","doi-asserted-by":"crossref","first-page":"E126","DOI":"10.3390\/molecules21010126","article-title":"Serum metabolomic characterization of liver fibrosis in rats and anti-fibrotic effects of Yin-Chen-Hao-Tang","volume":"21","author":"Zhang","year":"2016","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.biopha.2019.108701_bib0075","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1055\/s-2008-1040457","article-title":"Experimental models of hepatic fibrosis: a review","volume":"10","author":"Tsukamoto","year":"1990","journal-title":"Semin. Liver Dis."},{"issue":"3","key":"10.1016\/j.biopha.2019.108701_bib0080","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.jep.2011.02.013","article-title":"Hepatoprotective effects of Yi Guan Jian, an herbal medicine, in rats with dimethylnitrosamine-induced liver fibrosis","volume":"134","author":"Lin","year":"2011","journal-title":"J. Ethnopharmacol."},{"issue":"2","key":"10.1016\/j.biopha.2019.108701_bib0085","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.fct.2013.02.033","article-title":"Platycodi Radix attenuates dimethylnitrosamine-induced liver fibrosis in rats by inducing Nrf2-mediated antioxidant enzymes","volume":"56","author":"Choi","year":"2013","journal-title":"Food Chem. Toxicol."},{"issue":"4","key":"10.1016\/j.biopha.2019.108701_bib0090","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/s12291-013-0350-z","article-title":"Alleviation of dimethylnitrosamine-induced liver injury and fibrosis by supplementation of anabasis articulata extract in rats","volume":"29","author":"Mohamed","year":"2014","journal-title":"Indian J. Clin. Biochem."},{"key":"10.1016\/j.biopha.2019.108701_bib0095","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/217525","article-title":"A Chinese herbal medicine, jia-wei-xiao-yao-san, prevents dimethylnitrosamine-induced hepatic fibrosis in rats","volume":"2014","author":"Chien","year":"2014","journal-title":"Sci. World J."},{"key":"10.1016\/j.biopha.2019.108701_bib0100","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.taap.2015.12.024","article-title":"Dioscin alleviates BDL- and DMN-induced hepatic fibrosis via Sirt1\/Nrf2-mediated inhibition of p38 MAPK pathway","volume":"292","author":"Gu","year":"2016","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.biopha.2019.108701_bib0105","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jep.2015.12.053","article-title":"Hepatoprotective effects of Dicliptera chinensis polysaccharides on dimethylnitrosamine-induced hepatic fibrosis rats and its underlying mechanism","volume":"179","author":"Zhang","year":"2016","journal-title":"J. Ethnopharmacol."},{"issue":"11","key":"10.1016\/j.biopha.2019.108701_bib0110","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1039\/C4FO00342J","article-title":"Protective effects of garcinol on dimethylnitrosamine-induced liver fibrosis in rats","volume":"5","author":"Hung","year":"2014","journal-title":"Food Funct."},{"issue":"2","key":"10.1016\/j.biopha.2019.108701_bib0115","doi-asserted-by":"crossref","first-page":"G150","DOI":"10.1152\/ajpgi.00023.2017","article-title":"S-allyl-glutathione improves experimental liver fibrosis by regulating Kupffer cell activation in rats","volume":"314","author":"Takemura","year":"2018","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"2","key":"10.1016\/j.biopha.2019.108701_bib0120","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI24282","article-title":"Liver fibrosis","volume":"115","author":"Bataller","year":"2005","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.biopha.2019.108701_bib0125","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jpba.2010.03.015","article-title":"Metabonomics study of the protective effects of Lonicera japonica extract on acute liver injury in dimethylnitrosamine treated rats","volume":"53","author":"Sun","year":"2010","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.biopha.2019.108701_bib0130","doi-asserted-by":"crossref","first-page":"22151","DOI":"10.1038\/srep22151","article-title":"An integrated lipidomics and metabolomics reveal nephroprotective effect and biochemical mechanism of Rheum officinale in chronic renal failure","volume":"6","author":"Zhang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2019.108701_bib0135","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jpba.2017.03.031","article-title":"Urinary metabonomics study of the hepatoprotective effects of total alkaloids from Corydalis saxicola Bunting on carbon tetrachloride-induced chronic hepatotoxicity in rats using (1)H NMR analysis","volume":"140","author":"Wu","year":"2017","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.biopha.2019.108701_bib0140","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.intimp.2017.09.013","article-title":"Docosahexaenoic acid attenuates carbon tetrachloride-induced hepatic fibrosis in rats","volume":"53","author":"He","year":"2017","journal-title":"Int. Immunopharmacol."},{"issue":"3","key":"10.1016\/j.biopha.2019.108701_bib0145","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3945\/jn.112.171322","article-title":"Docosahexaenoic acid attenuates hepatic inflammation, oxidative stress, and fibrosis without decreasing hepatosteatosis in a Ldlr(-\/-) mouse model of western diet-induced nonalcoholic steatohepatitis","volume":"143","author":"Depner","year":"2013","journal-title":"J. Nutr."},{"issue":"23\u201324","key":"10.1016\/j.biopha.2019.108701_bib0150","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.lfs.2012.04.029","article-title":"The modulation of hepatic adenosine triphosphate and inflammation by eicosapentaenoic acid during severe fibrotic progression in the SHRSP5\/Dmcr rat model","volume":"90","author":"Jia","year":"2012","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.biopha.2019.108701_bib0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0121528","article-title":"Eicosapentaenoic acid ameliorates non-alcoholic steatohepatitis in a novel mouse model using melanocortin 4 receptor-deficient mice","volume":"10","author":"Konuma","year":"2015","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.biopha.2019.108701_bib0160","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1194\/jlr.M061275","article-title":"Docosahexaenoic acid attenuates Western diet-induced hepatic fibrosis in Ldlr-\/- mice by targeting the TGFbeta-Smad3 pathway","volume":"56","author":"Lytle","year":"2015","journal-title":"J. Lipid Res."},{"issue":"6","key":"10.1016\/j.biopha.2019.108701_bib0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0157580","article-title":"Different effects of eicosapentaenoic and docosahexaenoic acids on atherogenic high-fat diet-induced non-alcoholic fatty liver disease in mice","volume":"11","author":"Suzuki-Kemuriyama","year":"2016","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.biopha.2019.108701_bib0170","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.semcdb.2012.01.003","article-title":"PPARs: fatty acid sensors controlling metabolism","volume":"23","author":"Poulsen","year":"2012","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.biopha.2019.108701_bib0175","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1146\/annurev-nutr-071812-161139","article-title":"Fatty acid-regulated transcription factors in the liver","volume":"33","author":"Jump","year":"2013","journal-title":"Annu. Rev. Nutr."},{"issue":"8","key":"10.1016\/j.biopha.2019.108701_bib0180","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.bbadis.2011.02.014","article-title":"PPARs are a unique set of fatty acid regulated transcription factors controlling both lipid metabolism and inflammation","volume":"1812","author":"Varga","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"issue":"5","key":"10.1016\/j.biopha.2019.108701_bib0185","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1002\/hep.27297","article-title":"The transrepressive activity of peroxisome proliferator-activated receptor alpha is necessary and sufficient to prevent liver fibrosis in mice","volume":"60","author":"Pawlak","year":"2014","journal-title":"Hepatology"},{"issue":"40","key":"10.1016\/j.biopha.2019.108701_bib0190","doi-asserted-by":"crossref","first-page":"42530","DOI":"10.18632\/oncotarget.6466","article-title":"Oleoylethanolamide, an endogenous PPAR-alpha ligand, attenuates liver fibrosis targeting hepatic stellate cells","volume":"6","author":"Chen","year":"2015","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.biopha.2019.108701_bib0195","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S1499-3872(11)60009-X","article-title":"Peroxisome proliferator-activated receptor gamma inhibits hepatic fibrosis in rats","volume":"10","author":"Wang","year":"2011","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.biopha.2019.108701_bib0200","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1476-511X-12-11","article-title":"Activation of peroxisome proliferator activated receptor alpha ameliorates ethanol mediated liver fibrosis in mice","volume":"12","author":"Nan","year":"2013","journal-title":"Lipids Health Dis."},{"issue":"5","key":"10.1016\/j.biopha.2019.108701_bib0205","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.jhep.2011.12.008","article-title":"PPARalpha activation improves endothelial dysfunction and reduces fibrosis and portal pressure in cirrhotic rats","volume":"56","author":"Rodriguez-Vilarrupla","year":"2012","journal-title":"J. Hepatol."},{"issue":"46","key":"10.1016\/j.biopha.2019.108701_bib0210","doi-asserted-by":"crossref","first-page":"35715","DOI":"10.1074\/jbc.M006577200","article-title":"Peroxisome proliferator-activated receptors and hepatic stellate cell activation","volume":"275","author":"Miyahara","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.biopha.2019.108701_bib0215","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/1756283X09359964","article-title":"Treatment options for nonalcoholic fatty liver disease","volume":"3","author":"Lam","year":"2010","journal-title":"Therap. Adv. Gastroenterol."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218355823?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218355823?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T11:02:55Z","timestamp":1776078175000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332218355823"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":43,"alternative-id":["S0753332218355823"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2019.108701","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protective effect of cultured bear bile powder against dimethylnitrosamine-induced hepatic fibrosis in rats","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2019.108701","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"108701"}}